Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Shares Outstanding (Weighted Average) (2016 - 2025)

Bio-Techne (TECH) has 9 years of Shares Outstanding (Weighted Average) data on record, last reported at $39.3 million in Q4 2021.

  • For Q4 2021, Shares Outstanding (Weighted Average) rose 1.6% year-over-year to $39.3 million; the TTM value through Dec 2021 reached $39.3 million, up 1.6%, while the annual FY2021 figure was $38.7 million, 1.43% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $39.3 million in Q4 2021 per TECH's latest filing, up from $39.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $39.3 million in Q4 2021 and bottomed at $37.3 million in Q2 2017.
  • Average Shares Outstanding (Weighted Average) over 5 years is $38.1 million, with a median of $38.0 million recorded in 2019.
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 0.25% in 2017, then rose 1.6% in 2021.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $37.4 million in 2017, then grew by 0.85% to $37.8 million in 2018, then rose by 1.06% to $38.2 million in 2019, then grew by 1.37% to $38.7 million in 2020, then rose by 1.6% to $39.3 million in 2021.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $39.3 million in Q4 2021, $39.1 million in Q3 2021, and $38.7 million in Q2 2021.